ESC Premium Access

Influence of TCF21 rs12190287 in the coronary artery disease risk prediction. An association study in a Portuguese population.

Congress Presentation

About the speaker

Doctor Joao Sousa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)
4 presentations
0 follower

13 more presentations in this session

Identification of patients at extremely-high cardiovascular risk within a very-high risk population from the TERCET Registry.

Speaker: Associate Professor K. Dyrbus (Zabrze, PL)

Thumbnail

Risk Or Benefit IN Screening for CArdiovascular disease (ROBINSCA): results from screening for a high cardiovascular disease risk by using a risk prediction model or coronary artery calcium scoring

Speaker: Professor H. de Koning (Rotterdam, NL)

Thumbnail

Cystatin C based eGFR estimation compared to crea-based estimation equation for assessing risk of cardiovascular and total mortality in population-based studies and patients with manifest CVD

Speaker: Professor W. Koenig (Munich, DE)

Thumbnail

Definition of extremely high cardiovascular risk in patients after acute myocardial infarction - Data from the TERCET Registry.

Speaker: Associate Professor K. Dyrbus (Zabrze, PL)

Thumbnail

Comparison of APACHE II, SAPS II and GRACE 2.0 risk scores to estimate early and late mortality in patients with ST-segment elevation acute myocardial infarction.

Speaker: Doctor R. Arroyo-Espliguero (Guadalajara, ES)

Thumbnail

Access the full session

Poster Session 4 - Clinical risk factors, prevalence and prognosis

Speakers: Doctor J. Sousa, Associate Professor K. Dyrbus, Professor H. de Koning, Professor W. Koenig, Associate Professor K. Dyrbus...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb